FIELD: chemistry.
SUBSTANCE: invention relates to a compound [(4-dimethylaminophenyl)(2-chloroethoxy)phosphonyl]methane hydrazide of formula
as well as to a method for production thereof for improving cognitive functions and memory, reducing anxiety in cerebral dysfunction, as well as for correction of social deficit and elimination of symptoms of stereotyped behaviour in autism.
EFFECT: what is produced is a novel compound possessing biological activity for correction of disturbed neurological and mental functions of the brain.
3 cl, 7 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIPHENYLPHOSPHINO METHANE HYDRAZIDE, WHICH HAS BIOLOGICAL ACTIVITY, AND THE METHOD FOR ITS PREPARATION | 2021 |
|
RU2783121C1 |
| AGENT FOR CORRECTING AUTISM SPECTRUM DISORDERS | 2017 |
|
RU2666598C1 |
| ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
| METHOD OF TESTING PREPARATIONS WITH POTENTIAL PSYCOTROPIC OR ACT-PROTECTIVE ACTION | 2015 |
|
RU2601376C1 |
| 4-PHENYL PYRROLIDINONE-2 DERIVATIVE, NOOTROPIC COMPOSITION THEREOF, METHOD FOR PRODUCING THEREOF AND METHOD PREVENTIVE TREATMENT OF NERVOUS SYSTEM DISORDERS | 2015 |
|
RU2611623C2 |
| METHOD FOR MODELING ENCEPHALOPATHY IN OFFSPRING EXPOSED TO NON-TOXIC DOSES OF MANGANESE IN THE PRENATAL PERIOD | 2022 |
|
RU2794816C1 |
| COMPOSITION FOR COMFIT MANUFACTURING | 2017 |
|
RU2650548C1 |
| METHOD OF CORRECTING AGGRESSIVE BEHAVIOR CAUSED BY CHRONIC MODERATE STRESS | 2019 |
|
RU2714934C1 |
| 11-(4-TRET-BUTYLBENZYL) - AND PHENACYLREPLACED 2,3,4,5-TETRAHYDRO [1,3] DIAZEPINO [1,2-a] BENZIMIDAZOLE WITH ANXIOLYTIC ACTIVITY | 2016 |
|
RU2629022C1 |
| LITHIO-BETA-PHENYL-GAMMA-AMINOBUTYRATE AS MOOD STABILIZING AGENT | 2017 |
|
RU2677879C1 |
